Status:
UNKNOWN
Effect of Noninvasive Neuromodulation on Chronic Pain
Lead Sponsor:
Federal University of Paraíba
Conditions:
Temporomandibular Dysfunction (TMD)
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
1. BACKGROUND: Temporomandibular Dysfunction (TMD) is a disease characterized by a set of signs and symptoms that may include joint noise, pain in the mastication muscles, limitation of mandibular mov...
Eligibility Criteria
Inclusion
- Age between 18-60 years, both male and female
- Provide informed consent to participate in the study;
- Having a diagnosis of muscular pain DTM according to IA and IB, axis I RDC/TMD
- Visual analogic scale (VAS) score from 4 to 10 for six months or longer
- Presence of moderate depressive symptoms through SCL-90 scale evaluation of Axis II, (RDC / TMD)
- Not pregnant;
- Not have contraindications to tDCS, such as metal implants on the head or implanted brain devices;
- Not have history of alcohol or drugs abuse within the past 6 months as self-reported
- Not use of carbamazepine within the past 6 months as self reported
- Not have any history of epilepsy, stroke, moderate-to-severe traumatic brain injury or severe migraines
- Not have history of neurosurgery as self-reported
- Not have history of major psychiatric disorders such as schizophrenia and bipolar disorder
- Not have any other previously diagnosed disorder with symptoms similar to the DTM, such as fibromyalgia.
Exclusion
- Two absences during treatment sessions;
- During the research, go against some criteria of inclusion mentioned above, as in the case of women, getting pregnant.
Key Trial Info
Start Date :
October 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 16 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03285685
Start Date
October 2 2017
End Date
February 16 2018
Last Update
September 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tatyanne Falcão
João Pessoa, Paraíba, Brazil